Case Study
GLP-1 RA: Overcoming Known Pharmacological Effects
GLP-1 RA: Rapid Clinical Phase I Study Execution
Case Study—Nanosuspension Formulation to Maximize Potency for Preclinical Studies
Streamlining Clinical Trial Start-up for Accelerated Drug Development
Manufacturing With a Highly Potent API for an Ophthalmic Indication
Case Study―Evaluating Milling Conditions for Scaling Up a Nanosuspension Drug Product
Case Study― Assess the Safety, Tolerability, and Pharmacokinetics of Ascending Doses of Palovarotene (POS)
Case Study―Safety Assessment of Intravitreal Implants in Dutch Belted Rabbits
Case Study―Product Manufacturing and Analytical Testing for an Ocular Client
Rapid Development of a Liquid-filled, Hard-Shell Capsule Formulation of Cannabidiol